FB-102 is a monoclonal antibody commercialized by Forte Biosciences, with a lead...
TN-401 is a gene therapy commercialized by Tenaya Therapeutics, with a leading P...
CTX-131 is a gene-modified cell therapy commercialized by CRISPR Therapeutics, w...
Lemzoparlimab is a monoclonal antibody commercialized by I-Mab, with a leading P...
(Clesacostat tromethamine + Ervogastat) is a small molecule commercialized by Pf...
Imlunestrant tosylate is a small molecule commercialized by Eli Lilly and Co, wi...
ADI-001 is a gene-modified cell therapy commercialized by Adicet Bio, with a lea...
Rapcabtagene autoleucel is a gene-modified cell therapy commercialized by Novart...
Public health experts are anticipating a changing discourse following RFK Jr’s a...
AIM ImmunoTech has secured a patent from the Netherlands Patent Office for Ampli...
RLYB-116 is a fusion protein commercialized by Rallybio, with a leading Phase I ...
ORIC-944 is a small molecule commercialized by ORIC Pharmaceuticals, with a lead...
Rhenium (186Re) Obisbemeda is a small molecule commercialized by Plus Therapeuti...
The results from the Phase III trial found the LDL-C treatment to be well tolera...
The EMA has validated Chiesi Global Rare Diseases and Protalix’s submission to u...
The respiratory syncytial virus (RSV) prophylaxis market across the eight major ...
